Conventional chemotherapies are no longer the only treatment in multiple myelomatosis. High-dose chemotherapy and autologous transplantation are not curative but do increase relapse-free survival time in young patients. Thalidomide is efficacious in refractory and relapsing myeloma and its evaluation is ...
“I tell myfellowsthat my goal is not to cure myeloma. It’s to give my patients the longest life, with the best quality of life, with the least amount of treatment necessary. That goal is met by achieving the deepest response—by getting to a complete remission. The use of optimal in...
Learn about multiple myeloma treatment options available for patients from Bristol Myers Squibb®. Please see Indication and Important Safety Information including Boxed WARNINGS.
home / satellite-sessions / treatment-of-multiple-myeloma-best-practices-from-city-of-hope-and-satellites Experts from City of Hope reflect on the current treatment landscape of multiple myeloma and how clinical data are applied to their practice within the main campus and satell...
Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.EP: 1.Pharmacists in Multiple Myeloma Care: Essential Roles and Patient Support EP: 2.Eligibility Factors in Multiple Myeloma ...
The best results have been reported for patients receiving myeloablative treatment at the time of early first remission, with median survival times extended to over 5 years (Attal et al., 1992; Cunningham et al., 1994). With myeloma, unlike lymphoma, virtually all patients develop recurrent ...
Interferon is another type of immunotherapy. Bone marrow cells and some white blood cells release this hormone-like substance. When it's used as a drug, it can slow the growth of myeloma cells. You might takeinterferonif you've had treatment and are in remission, which means your doctor ca...
myeloma and PCPDs, staging andrisk stratification, and treatment are briefly described as they pertain to neurologic complications. A brief overview of the imaging of multiple myeloma and then specific imaging findings associated with common neurologic complications seen with multiple myeloma are described...
In addition to emerging treatment options, the speakers addressed the importance of individualized decision-making when treating patients with multiple myeloma. Image credit: freshidea | stock.adobe.com During a presentation at the National Comprehensive Cancer Network Annual 2024 Conference in Orlando, ...
The present disclosure relates to the treatment of multiple myeloma. Monoclonal antibody MOR202 is efficacious when administered to patient at certain dosage regimens.